{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:35:41Z","timestamp":1790368541185,"version":"4.1.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T00:00:00Z","timestamp":1358640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00467-012-2329-z","type":"journal-article","created":{"date-parts":[[2013,1,19]],"date-time":"2013-01-19T03:44:40Z","timestamp":1358567080000},"page":"1923-1942","source":"Crossref","is-referenced-by-count":232,"title":["Hereditary causes of kidney stones and chronic kidney disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Vidar O.","family":"Edvardsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lada","family":"Beara-Lasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Anglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn S.","family":"Milliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runolfur","family":"Palsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,20]]},"reference":[{"key":"2329_CR1","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.2215\/CJN.11191210","volume":"6","author":"DJ Sas","year":"2011","unstructured":"Sas DJ (2011) An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clin J Am Soc Nephrol 6:2062\u20132068","journal-title":"Clin J Am Soc Nephrol"},{"key":"2329_CR2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1046\/j.1523-1755.2003.00917.x","volume":"63","author":"KK Stamatelou","year":"2003","unstructured":"Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976\u20131994. Kidney Int 63:1817\u20131823","journal-title":"Kidney Int"},{"issue":"6","key":"2329_CR3","first-page":"1","volume":"10","author":"L Beara-Lasic","year":"2011","unstructured":"Beara-Lasic L, Edvardsson V, Palsson R, Lieske J, Goldfarb D, Milliner D (2011) Genetic causes of kidney stones and kidney failure. Clin Rev Bone Miner Metab 10(6):1\u201318","journal-title":"Clin Rev Bone Miner Metab"},{"key":"2329_CR4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00442515","volume":"138","author":"MC Greenwood","year":"1982","unstructured":"Greenwood MC, Dillon MJ, Simmonds HA, Barratt TM, Pincott JR, Metreweli C (1982) Renal failure due to 2,8-dihydroxyadenine urolithiasis. Eur J Pediatr 138:346\u2013349","journal-title":"Eur J Pediatr"},{"key":"2329_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1681\/ASN.2007060709","volume":"19","author":"M Konrad","year":"2008","unstructured":"Konrad M, Hou J, Weber S, Dotsch J, Kari JA, Seeman T, Kuwertz-Broking E, Peco-Antic A, Tasic V, Dittrich K, Alshaya HO, von Vigier RO, Gallati S, Goodenough DA, Schaller A (2008) CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 19:171\u2013181","journal-title":"J Am Soc Nephrol"},{"key":"2329_CR6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","volume":"75","author":"B Hoppe","year":"2009","unstructured":"Hoppe B, Beck BB, Milliner DS (2009) The primary hyperoxalurias. Kidney Int 75:1264\u20131271","journal-title":"Kidney Int"},{"key":"2329_CR7","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2215\/CJN.10651110","volume":"6","author":"AD Rule","year":"2011","unstructured":"Rule AD, Krambeck AE, Lieske JC (2011) Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6:2069\u20132075","journal-title":"Clin J Am Soc Nephrol"},{"key":"2329_CR8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/ajkd.2001.26826","volume":"38","author":"V Edvardsson","year":"2001","unstructured":"Edvardsson V, Palsson R, Olafsson I, Hjaltadottir G, Laxdal T (2001) Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland. Am J Kidney Dis 38:473\u2013480","journal-title":"Am J Kidney Dis"},{"key":"2329_CR9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1681\/ASN.2009080808","volume":"21","author":"G Bollee","year":"2010","unstructured":"Bollee G, Dollinger C, Boutaud L, Guillemot D, Bensman A, Harambat J, Deteix P, Daudon M, Knebelmann B, Ceballos-Picot I (2010) Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol 21:679\u2013688","journal-title":"J Am Soc Nephrol"},{"key":"2329_CR10","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1172\/JCI105913","volume":"47","author":"WN Kelley","year":"1968","unstructured":"Kelley WN, Levy RI, Rosenbloom FM, Henderson JF, Seegmiller JE (1968) Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest 47:2281\u20132289","journal-title":"J Clin Invest"},{"key":"2329_CR11","first-page":"2571","volume-title":"The metabolic and molecular bases of inherited disease","author":"AS Sahota","year":"2001","unstructured":"Sahota AS, Tischfield AJ, Kamatani N, Simmonds HA (2001) Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadenine lithiasis. In: Scriver CRBA, Sly WS, Valle D, Vogelstein B, Childs B (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2571\u20132584"},{"key":"2329_CR12","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1073\/pnas.84.10.3349","volume":"84","author":"TP Broderick","year":"1987","unstructured":"Broderick TP, Schaff DA, Bertino AM, Dush MK, Tischfield JA, Stambrook PJ (1987) Comparative anatomy of the human APRT gene and enzyme: nucleotide sequence divergence and conservation of a nonrandom CpG dinucleotide arrangement. Proc Natl Acad Sci U S A 84:3349\u20133353","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2329_CR13","unstructured":"Edvardsson VO, Palsson R, Sahota A (2012) Adenine Phosphoribosyltransferase Deficiency In: GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Copyright, University of Washington, Seattle, 1997\u20132010. Available at http:\/\/www.genetests.org"},{"key":"2329_CR14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1172\/JCI115825","volume":"90","author":"N Kamatani","year":"1992","unstructured":"Kamatani N, Hakoda M, Otsuka S, Yoshikawa H, Kashiwazaki S (1992) Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients. J Clin Invest 90:130\u2013135","journal-title":"J Clin Invest"},{"key":"2329_CR15","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/ndt\/gfp711","volume":"25","author":"SH Nasr","year":"2010","unstructured":"Nasr SH, Sethi S, Cornell LD, Milliner DS, Boelkins M, Broviac J, Fidler ME (2010) Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol Dial Transplant 25:1909\u20131915","journal-title":"Nephrol Dial Transplant"},{"key":"2329_CR16","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1093\/nar\/15.21.9086","volume":"15","author":"Y Hidaka","year":"1987","unstructured":"Hidaka Y, Tarle SA, O\u2019Toole TE, Kelley WN, Palella TD (1987) Nucleotide sequence of the human APRT gene. Nucleic Acids Res 15:9086","journal-title":"Nucleic Acids Res"},{"key":"2329_CR17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/hmg\/3.5.817","volume":"3","author":"A Sahota","year":"1994","unstructured":"Sahota A, Chen J, Boyadjiev SA, Gault MH, Tischfield JA (1994) Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8-dihydroxyadenine urolithiasis. Hum Mol Genet 3:817\u2013818","journal-title":"Hum Mol Genet"},{"key":"2329_CR18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00467-011-2037-0","volume":"27","author":"J Harambat","year":"2012","unstructured":"Harambat J, Bollee G, Daudon M, Ceballos-Picot I, Bensman A (2012) Adenine phosphoribosyltransferase deficiency in children. Pediatr Nephrol 27:571\u2013579","journal-title":"Pediatr Nephrol"},{"key":"2329_CR19","first-page":"762","volume":"10","author":"H Debray","year":"1976","unstructured":"Debray H, Cartier P, Temstet A, Cendron J (1976) Child\u2019s urinary lithiasis revealing a complete deficit in adenine phosphoribosyl transferase. Pediatr Res 10:762\u2013766","journal-title":"Pediatr Res"},{"key":"2329_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0009-8981(88)90318-X","volume":"172","author":"P Chiba","year":"1988","unstructured":"Chiba P, Zwiauer K, Muller MM (1988) Characterization of an adenine phosphoribosyltransferase deficiency. Clin Chim Acta 172:141\u2013147","journal-title":"Clin Chim Acta"},{"key":"2329_CR21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/ndt\/gfg562","volume":"19","author":"MJ Cassidy","year":"2004","unstructured":"Cassidy MJ, McCulloch T, Fairbanks LD, Simmonds HA (2004) Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient. Nephrol Dial Transplant 19:736\u2013738","journal-title":"Nephrol Dial Transplant"},{"key":"2329_CR22","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1016\/S0272-6386(05)90001-2","volume":"37","author":"B Benedetto","year":"2001","unstructured":"Benedetto B, Madden R, Kurbanov A, Braden G, Freeman J, Lipkowitz GS (2001) Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction. Am J Kidney Dis 37:E37","journal-title":"Am J Kidney Dis"},{"key":"2329_CR23","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","volume":"52","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Palo WA, Eustace D, Vernillet L, Joseph-Ridge N (2005) Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose\u2013response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum 52:916\u2013923","journal-title":"Arthritis Rheum"},{"key":"2329_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0025-6196(12)60043-3","volume":"68","author":"DS Milliner","year":"1993","unstructured":"Milliner DS, Murphy ME (1993) Urolithiasis in pediatric patients. Mayo Clin Proc 68:241\u2013248","journal-title":"Mayo Clin Proc"},{"key":"2329_CR25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrneph.2010.69","volume":"6","author":"J Chillaron","year":"2010","unstructured":"Chillaron J, Font-Llitjos M, Fort J, Zorzano A, Goldfarb DS, Nunes V, Palacin M (2010) Pathophysiology and treatment of cystinuria. Nat Rev Nephrol 6:424\u2013434","journal-title":"Nat Rev Nephrol"},{"key":"2329_CR26","doi-asserted-by":"crossref","first-page":"F540","DOI":"10.1152\/ajprenal.00071.2002","volume":"283","author":"E Fernandez","year":"2002","unstructured":"Fernandez E, Carrascal M, Rousaud F, Abian J, Zorzano A, Palacin M, Chillaron J (2002) rBAT-b(0,+)AT heterodimer is the main apical reabsorption system for cystine in the kidney. Am J Physiol Renal Physiol 283:F540\u2013548","journal-title":"Am J Physiol Renal Physiol"},{"key":"2329_CR27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2174\/156652408785747997","volume":"8","author":"K Martens","year":"2008","unstructured":"Martens K, Jaeken J, Matthijs G, Creemers JW (2008) Multi-system disorder syndromes associated with cystinuria type I. Curr Mol Med 8:544\u2013550","journal-title":"Curr Mol Med"},{"key":"2329_CR28","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00467-007-0575-2","volume":"22","author":"L Dello Strologo","year":"2007","unstructured":"Dello Strologo L, Laurenzi C, Legato A, Pastore A (2007) Cystinuria in children and young adults: success of monitoring free-cystine urine levels. Pediatr Nephrol 22:1869\u20131873","journal-title":"Pediatr Nephrol"},{"key":"2329_CR29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/end.2010.0133","volume":"24","author":"EH Lambert","year":"2010","unstructured":"Lambert EH, Asplin JR, Herrell SD, Miller NL (2010) Analysis of 24-hour urine parameters as it relates to age of onset of cystine stone formation. J Endourol 24:1179\u20131182","journal-title":"J Endourol"},{"key":"2329_CR30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1464-410X.2006.06169.x","volume":"97","author":"EM Worcester","year":"2006","unstructured":"Worcester EM, Coe FL, Evan AP, Parks JH (2006) Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int 97:1285\u20131290","journal-title":"BJU Int"},{"key":"2329_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-5347(05)64824-0","volume":"168","author":"DG Assimos","year":"2002","unstructured":"Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168:27\u201330","journal-title":"J Urol"},{"key":"2329_CR32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0009-8981(99)00159-X","volume":"289","author":"Y Nakagawa","year":"1999","unstructured":"Nakagawa Y, Coe FL (1999) A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta 289:57\u201368","journal-title":"Clin Chim Acta"},{"key":"2329_CR33","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/sj.ki.5000268","volume":"69","author":"AP Evan","year":"2006","unstructured":"Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227\u20132235","journal-title":"Kidney Int"},{"key":"2329_CR34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1523-1755.2005.67100.x","volume":"67","author":"M Boutros","year":"2005","unstructured":"Boutros M, Vicanek C, Rozen R, Goodyer P (2005) Transient neonatal cystinuria. Kidney Int 67:443\u2013448","journal-title":"Kidney Int"},{"key":"2329_CR35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/sj.ki.5000104","volume":"69","author":"DS Goldfarb","year":"2006","unstructured":"Goldfarb DS, Coe FL, Asplin JR (2006) Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int 69:1041\u20131047","journal-title":"Kidney Int"},{"key":"2329_CR36","first-page":"273","volume":"22","author":"JS Rodman","year":"1984","unstructured":"Rodman JS, Blackburn P, Williams JJ, Brown A, Pospischil MA, Peterson CM (1984) The effect of dietary protein on cystine excretion in patients with cystinuria. Clin Nephrol 22:273\u2013278","journal-title":"Clin Nephrol"},{"key":"2329_CR37","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0022-5347(01)65451-X","volume":"156","author":"GK Chow","year":"1996","unstructured":"Chow GK, Streem SB (1996) Medical treatment of cystinuria: results of contemporary clinical practice. J Urol 156:1576\u20131578","journal-title":"J Urol"},{"key":"2329_CR38","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0022-5347(05)67011-5","volume":"164","author":"Y Nakagawa","year":"2000","unstructured":"Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL (2000) Clinical use of cystine supersaturation measurements. J Urol 164:1481\u20131485","journal-title":"J Urol"},{"key":"2329_CR39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/end.2005.19.429","volume":"19","author":"DJ Dolin","year":"2005","unstructured":"Dolin DJ, Asplin JR, Flagel L, Grasso M, Goldfarb DS (2005) Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol 19:429\u2013432","journal-title":"J Endourol"},{"key":"2329_CR40","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1097\/01.ju.0000181817.89703.66","volume":"174","author":"G Pareek","year":"2005","unstructured":"Pareek G, Steele TH, Nakada SY (2005) Urological intervention in patients with cystinuria is decreased with medical compliance. J Urol 174:2250\u20132252","journal-title":"J Urol"},{"key":"2329_CR41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00240-007-0089-1","volume":"35","author":"A Trinchieri","year":"2007","unstructured":"Trinchieri A, Montanari E, Zanetti G, Lizzano R (2007) The impact of new technology in the treatment of cystine stones. Urol Res 35:129\u2013132","journal-title":"Urol Res"},{"key":"2329_CR42","first-page":"473","volume":"87","author":"OM Wrong","year":"1994","unstructured":"Wrong OM, Norden AG, Feest TG (1994) Dent\u2019s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. Q J Med 87:473\u2013493","journal-title":"Q J Med"},{"key":"2329_CR43","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/hmg\/6.8.1233","volume":"6","author":"SE Lloyd","year":"1997","unstructured":"Lloyd SE, Gunther W, Pearce SH, Thomson A, Bianchi ML, Bosio M, Craig IW, Fisher SE, Scheinman SJ, Wrong O, Jentsch TJ, Thakker RV (1997) Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet 6:1233\u20131239","journal-title":"Hum Mol Genet"},{"key":"2329_CR44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1523-1755.2000.00916.x","volume":"57","author":"RV Thakker","year":"2000","unstructured":"Thakker RV (2000) Pathogenesis of Dent\u2019s disease and related syndromes of X-linked nephrolithiasis. Kidney Int 57:787\u2013793","journal-title":"Kidney Int"},{"key":"2329_CR45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1681\/ASN.V571451","volume":"5","author":"SC Reinhart","year":"1995","unstructured":"Reinhart SC, Norden AG, Lapsley M, Thakker RV, Pang J, Moses AM, Frymoyer PA, Favus MJ, Hoepner JA, Scheinman SJ (1995) Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol 5:1451\u20131461","journal-title":"J Am Soc Nephrol"},{"key":"2329_CR46","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.V1171331","volume":"11","author":"S Waldegger","year":"2000","unstructured":"Waldegger S, Jentsch TJ (2000) From tonus to tonicity: physiology of CLC chloride channels. J Am Soc Nephrol 11:1331\u20131339","journal-title":"J Am Soc Nephrol"},{"key":"2329_CR47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0014-5793(04)00210-8","volume":"564","author":"R Dutzler","year":"2004","unstructured":"Dutzler R (2004) Structural basis for ion conduction and gating in ClC chloride channels. FEBS Lett 564:229\u2013233","journal-title":"FEBS Lett"},{"key":"2329_CR48","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1073\/pnas.95.14.8075","volume":"95","author":"W Gunther","year":"1998","unstructured":"Gunther W, Luchow A, Cluzeaud F, Vandewalle A, Jentsch TJ (1998) ClC-5, the chloride channel mutated in Dent\u2019s disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci U S A 95:8075\u20138080","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2329_CR49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/hmg\/8.2.247","volume":"8","author":"O Devuyst","year":"1999","unstructured":"Devuyst O, Christie PT, Courtoy PJ, Beauwens R, Thakker RV (1999) Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent\u2019s disease. Hum Mol Genet 8:247\u2013257","journal-title":"Hum Mol Genet"},{"key":"2329_CR50","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bbrc.2005.02.060","volume":"329","author":"M Hara-Chikuma","year":"2005","unstructured":"Hara-Chikuma M, Wang Y, Guggino SE, Guggino WB, Verkman AS (2005) Impaired acidification in early endosomes of ClC-5 deficient proximal tubule. Biochem Biophys Res Commun 329:941\u2013946","journal-title":"Biochem Biophys Res Commun"},{"key":"2329_CR51","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature03720","volume":"436","author":"A Picollo","year":"2005","unstructured":"Picollo A, Pusch M (2005) Chloride\/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436:420\u2013423","journal-title":"Nature"},{"key":"2329_CR52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature03860","volume":"436","author":"O Scheel","year":"2005","unstructured":"Scheel O, Zdebik AA, Lourdel S, Jentsch TJ (2005) Voltage-dependent electrogenic chloride\/proton exchange by endosomal CLC proteins. Nature 436:424\u2013427","journal-title":"Nature"},{"key":"2329_CR53","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.1188070","volume":"328","author":"G Novarino","year":"2010","unstructured":"Novarino G, Weinert S, Rickheit G, Jentsch TJ (2010) Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science 328:1398\u20131401","journal-title":"Science"},{"key":"2329_CR54","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1074\/jbc.274.2.896","volume":"274","author":"T Friedrich","year":"1999","unstructured":"Friedrich T, Breiderhoff T, Jentsch TJ (1999) Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents. J Biol Chem 274:896\u2013902","journal-title":"J Biol Chem"},{"key":"2329_CR55","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biocel.2005.09.009","volume":"38","author":"DH Hryciw","year":"2006","unstructured":"Hryciw DH, Ekberg J, Pollock CA, Poronnik P (2006) ClC-5: a chloride channel with multiple roles in renal tubular albumin uptake. Int J Biochem Cell Biol 38:1036\u20131042","journal-title":"Int J Biochem Cell Biol"},{"key":"2329_CR56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/35042597","volume":"408","author":"N Piwon","year":"2000","unstructured":"Piwon N, Gunther W, Schwake M, Bosl MR, Jentsch TJ (2000) ClC-5 Cl--channel disruption impairs endocytosis in a mouse model for Dent\u2019s disease. Nature 408:369\u2013373","journal-title":"Nature"},{"key":"2329_CR57","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/hmg\/9.20.2937","volume":"9","author":"SS Wang","year":"2000","unstructured":"Wang SS, Devuyst O, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakker RV, Guggino S, Guggino WB (2000) Mice lacking renal chloride channel, CLC-5, are a model for Dent\u2019s disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 9:2937\u20132945","journal-title":"Hum Mol Genet"},{"key":"2329_CR58","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1073\/pnas.1432873100","volume":"100","author":"EI Christensen","year":"2003","unstructured":"Christensen EI, Devuyst O, Dom G, Nielsen R, Van der Smissen P, Verroust P, Leruth M, Guggino WB, Courtoy PJ (2003) Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci U S A 100:8472\u20138477","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2329_CR59","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1359\/jbmr.2003.18.4.615","volume":"18","author":"IV Silva","year":"2003","unstructured":"Silva IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O, Thakker RV, Guggino WB, Guggino SE (2003) The ClC-5 knockout mouse model of Dent\u2019s disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res 18:615\u2013623","journal-title":"J Bone Miner Res"},{"key":"2329_CR60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1096\/fj.02-0578fje","volume":"17","author":"JR Leheste","year":"2003","unstructured":"Leheste JR, Melsen F, Wellner M, Jansen P, Schlichting U, Renner-Muller I, Andreassen TT, Wolf E, Bachmann S, Nykjaer A, Willnow TE (2003) Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 17:247\u2013249","journal-title":"FASEB J"},{"key":"2329_CR61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1750-1172-5-28","volume":"5","author":"O Devuyst","year":"2010","unstructured":"Devuyst O, Thakker RV (2010) Dent\u2019s disease. Orphanet J Rare Dis 5:28","journal-title":"Orphanet J Rare Dis"},{"key":"2329_CR62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00467-010-1657-0","volume":"26","author":"F Claverie-Martin","year":"2011","unstructured":"Claverie-Martin F, Ramos-Trujillo E, Garcia-Nieto V (2011) Dent\u2019s disease: clinical features and molecular basis. Pediatr Nephrol 26:693\u2013704","journal-title":"Pediatr Nephrol"},{"key":"2329_CR63","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1523-1755.2004.00571.x","volume":"65","author":"RR Hoopes Jr","year":"2004","unstructured":"Hoopes RR Jr, Raja KM, Koich A, Hueber P, Reid R, Knohl SJ, Scheinman SJ (2004) Evidence for genetic heterogeneity in Dent\u2019s disease. Kidney Int 65:1615\u20131620","journal-title":"Kidney Int"},{"key":"2329_CR64","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/427887","volume":"76","author":"RR Hoopes Jr","year":"2005","unstructured":"Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL, Scheinman SJ (2005) Dent Disease with mutations in OCRL1. Am J Hum Genet 76:260\u2013267","journal-title":"Am J Hum Genet"},{"key":"2329_CR65","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ncb0905-851","volume":"7","author":"Y Ghanekar","year":"2005","unstructured":"Ghanekar Y, Lowe M (2005) Signalling for secretion. Nat Cell Biol 7:851\u2013853","journal-title":"Nat Cell Biol"},{"key":"2329_CR66","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1091\/mbc.E05-02-0120","volume":"16","author":"R Choudhury","year":"2005","unstructured":"Choudhury R, Diao A, Zhang F, Eisenberg E, Saint-Pol A, Williams C, Konstantakopoulos A, Lucocq J, Johannes L, Rabouille C, Greene LE, Lowe M (2005) Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell 16:3467\u20133479","journal-title":"Mol Biol Cell"},{"key":"2329_CR67","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00467-009-1228-4","volume":"24","author":"E Tosetto","year":"2009","unstructured":"Tosetto E, Addis M, Caridi G, Meloni C, Emma F, Vergine G, Stringini G, Papalia T, Barbano G, Ghiggeri GM, Ruggeri L, Miglietti N, D Angelo A, Melis MA, Anglani F (2009) Locus heterogeneity of Dent\u2019s disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations. Pediatr Nephrol 24:1967\u20131973","journal-title":"Pediatr Nephrol"},{"key":"2329_CR68","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.21391","volume":"32","author":"H Hichri","year":"2011","unstructured":"Hichri H, Rendu J, Monnier N, Coutton C, Dorseuil O, Poussou RV, Baujat G, Blanchard A, Nobili F, Ranchin B, Remesy M, Salomon R, Satre V, Lunardi J (2011) From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat 32:379\u2013388","journal-title":"Hum Mutat"},{"key":"2329_CR69","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2215\/CJN.00900207","volume":"2","author":"L Copelovitch","year":"2007","unstructured":"Copelovitch L, Nash MA, Kaplan BS (2007) Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2:914\u2013918","journal-title":"Clin J Am Soc Nephrol"},{"key":"2329_CR70","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00467-009-1299-2","volume":"24","author":"Y Frishberg","year":"2009","unstructured":"Frishberg Y, Dinour D, Belostotsky R, Becker-Cohen R, Rinat C, Feinstein S, Navon-Elkan P, Ben-Shalom E (2009) Dent\u2019s disease manifesting as focal glomerulosclerosis: is it the tip of the iceberg? Pediatr Nephrol 24:2369\u20132373","journal-title":"Pediatr Nephrol"},{"key":"2329_CR71","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpeds.2009.01.049","volume":"155","author":"A Bokenkamp","year":"2009","unstructured":"Bokenkamp A, Bockenhauer D, Cheong HI, Hoppe B, Tasic V, Unwin R, Ludwig M (2009) Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 155:94\u201399","journal-title":"J Pediatr"},{"key":"2329_CR72","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/clinchem\/28.6.1330","volume":"28","author":"PG Davey","year":"1982","unstructured":"Davey PG, Gosling P (1982) Beta 2-microglobulin instability in pathological urine. Clin Chem 28:1330\u20131333","journal-title":"Clin Chem"},{"key":"2329_CR73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000045245","volume":"81","author":"S Suzuki","year":"1999","unstructured":"Suzuki S, Suzuki J, Kume K, Yoshida K, Suyama H, Kawasaki Y, Nozawa R, Suzuki H, Fujiki T, Kamiyama S, Suzuki A (1999) Poor renal accumulation of 99mTc-DMSA in idiopathic tubular proteinuria. Nephron 81:49\u201354","journal-title":"Nephron"},{"key":"2329_CR74","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1523-1755.2005.00442.x","volume":"68","author":"V Cebotaru","year":"2005","unstructured":"Cebotaru V, Kaul S, Devuyst O, Cai H, Racusen L, Guggino WB, Guggino SE (2005) High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent\u2019s disease. Kidney Int 68:642\u2013652","journal-title":"Kidney Int"},{"key":"2329_CR75","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0026-0495(72)90025-X","volume":"21","author":"MF Michelis","year":"1972","unstructured":"Michelis MF, Drash AL, Linarelli LG, De Rubertis FR, Davis BB (1972) Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis. (Evaluation of the pathophysiological role of parathyroid hormone). Metabolism 21:905\u2013920","journal-title":"Metabolism"},{"key":"2329_CR76","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1681\/ASN.V1291872","volume":"12","author":"S Weber","year":"2001","unstructured":"Weber S, Schneider L, Peters M, Misselwitz J, Ronnefarth G, Boswald M, Bonzel KE, Seeman T, Sulakova T, Kuwertz-Broking E, Gregoric A, Palcoux JB, Tasic V, Manz F, Scharer K, Seyberth HW, Konrad M (2001) Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 12:1872\u20131881","journal-title":"J Am Soc Nephrol"},{"key":"2329_CR77","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2215\/CJN.02870310","volume":"6","author":"S Faguer","year":"2011","unstructured":"Faguer S, Chauveau D, Cintas P, Tack I, Cointault O, Rostaing L, Vargas-Poussou R, Ribes D (2011) Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations. Clin J Am Soc Nephrol 6:355\u2013360","journal-title":"Clin J Am Soc Nephrol"},{"key":"2329_CR78","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2215\/CJN.12841211","volume":"7","author":"A Godron","year":"2012","unstructured":"Godron A, Harambat J, Boccio V, Mensire A, May A, Rigothier C, Couzi L, Barrou B, Godin M, Chauveau D, Faguer S, Vallet M, Cochat P, Eckart P, Guest G, Guigonis V, Houillier P, Blanchard A, Jeunemaitre X, Vargas-Poussou R (2012) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Clin J Am Soc Nephrol 7:801\u2013809","journal-title":"Clin J Am Soc Nephrol"},{"key":"2329_CR79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00849255","volume":"1","author":"J Rodriguez-Soriano","year":"1987","unstructured":"Rodriguez-Soriano J, Vallo A, Garcia-Fuentes M (1987) Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol 1:465\u2013472","journal-title":"Pediatr Nephrol"},{"key":"2329_CR80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.285.5424.103","volume":"285","author":"DB Simon","year":"1999","unstructured":"Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285:103\u2013106","journal-title":"Science"},{"key":"2329_CR81","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1086\/508617","volume":"79","author":"M Konrad","year":"2006","unstructured":"Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, Lesslauer A, Vitzthum H, Suzuki Y, Luk JM, Becker C, Schlingmann KP, Schmid M, Rodriguez-Soriano J, Ariceta G, Cano F, Enriquez R, Juppner H, Bakkaloglu SA, Hediger MA, Gallati S, Neuhauss SC, Nurnberg P, Weber S (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79:949\u2013957","journal-title":"Am J Hum Genet"},{"key":"2329_CR82","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00467-011-1824-y","volume":"26","author":"J Li","year":"2011","unstructured":"Li J, Ananthapanyasut W, Yu AS (2011) Claudins in renal physiology and disease. Pediatr Nephrol 26:2133\u20132142","journal-title":"Pediatr Nephrol"},{"key":"2329_CR83","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1046\/j.1523-1755.2001.00736.x","volume":"59","author":"A Blanchard","year":"2001","unstructured":"Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, Demontis R, Fournier A, Paillard M, Houillier P (2001) Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59:2206\u20132215","journal-title":"Kidney Int"},{"key":"2329_CR84","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ajkd.2010.08.038","volume":"57","author":"L Haisch","year":"2011","unstructured":"Haisch L, Almeida JR, Abreu da Silva PR, Schlingmann KP, Konrad M (2011) The role of tight junctions in paracellular ion transport in the renal tubule: lessons learned from a rare inherited tubular disorder. Am J Kidney Dis 57:320\u2013330","journal-title":"Am J Kidney Dis"},{"key":"2329_CR85","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1681\/ASN.V134875","volume":"13","author":"Y Kiuchi-Saishin","year":"2002","unstructured":"Kiuchi-Saishin Y, Gotoh S, Furuse M, Takasuga A, Tano Y, Tsukita S (2002) Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 13:875\u2013886","journal-title":"J Am Soc Nephrol"},{"key":"2329_CR86","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1242\/jcs.02631","volume":"118","author":"J Hou","year":"2005","unstructured":"Hou J, Paul DL, Goodenough DA (2005) Paracellin-1 and the modulation of ion selectivity of tight junctions. J Cell Sci 118:5109\u20135118","journal-title":"J Cell Sci"},{"key":"2329_CR87","first-page":"619","volume":"118","author":"J Hou","year":"2008","unstructured":"Hou J, Renigunta A, Konrad M, Gomes AS, Schneeberger EE, Paul DL, Waldegger S, Goodenough DA (2008) Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 118:619\u2013628","journal-title":"J Clin Invest"},{"key":"2329_CR88","doi-asserted-by":"crossref","first-page":"15350","DOI":"10.1073\/pnas.0907724106","volume":"106","author":"J Hou","year":"2009","unstructured":"Hou J, Renigunta A, Gomes AS, Hou M, Paul DL, Waldegger S, Goodenough DA (2009) Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci U S A 106:15350\u201315355","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2329_CR89","doi-asserted-by":"crossref","first-page":"17114","DOI":"10.1074\/jbc.M700632200","volume":"282","author":"J Hou","year":"2007","unstructured":"Hou J, Shan Q, Wang T, Gomes AS, Yan Q, Paul DL, Bleich M, Goodenough DA (2007) Transgenic RNAi depletion of claudin-16 and the renal handling of magnesium. J Biol Chem 282:17114\u201317122","journal-title":"J Biol Chem"},{"key":"2329_CR90","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1172\/JCI26323","volume":"116","author":"PJ Kausalya","year":"2006","unstructured":"Kausalya PJ, Amasheh S, Gunzel D, Wurps H, Muller D, Fromm M, Hunziker W (2006) Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16. J Clin Invest 116:878\u2013891","journal-title":"J Clin Invest"},{"key":"2329_CR91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2369-9-12","volume":"9","author":"G Hampson","year":"2008","unstructured":"Hampson G, Konrad MA, Scoble J (2008) Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene. BMC Nephrol 9:12","journal-title":"BMC Nephrol"},{"key":"2329_CR92","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00467-008-0807-0","volume":"24","author":"MJ Stechman","year":"2009","unstructured":"Stechman MJ, Loh NY, Thakker RV (2009) Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol 24:2321\u20132332","journal-title":"Pediatr Nephrol"},{"key":"2329_CR93","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/ki.1995.199","volume":"47","author":"M Praga","year":"1995","unstructured":"Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419\u20131425","journal-title":"Kidney Int"},{"key":"2329_CR94","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/ndt\/gfl144","volume":"21","author":"B Zimmermann","year":"2006","unstructured":"Zimmermann B, Plank C, Konrad M, Stohr W, Gravou-Apostolatou C, Rascher W, Dotsch J (2006) Hydrochlorothiazide in CLDN16 mutation. Nephrol Dial Transplant 21:2127\u20132132","journal-title":"Nephrol Dial Transplant"},{"key":"2329_CR95","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0022-5347(17)36954-9","volume":"148","author":"JC Lieske","year":"1992","unstructured":"Lieske JC, Spargo BH, Toback FG (1992) Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 148:1517\u20131519","journal-title":"J Urol"},{"key":"2329_CR96","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000059894","volume-title":"Hereditary kidney diseases","author":"AO Muda","year":"1997","unstructured":"Muda AO, Barsotti P, Rinaldi S, Rizzoni G, Faraggiana T (1997) Renal pathology in hyperoxaluria. In: Sessa A, Conte F, Meroni M, Battini G (eds) Hereditary kidney diseases. Karger, Basel, pp 160\u2013166"},{"key":"2329_CR97","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ndt\/18.2.273","volume":"18","author":"CS Woerden van","year":"2003","unstructured":"van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA (2003) Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 18:273\u2013279","journal-title":"Nephrol Dial Transplant"},{"key":"2329_CR98","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00467-006-0124-4","volume":"21","author":"P Cochat","year":"2006","unstructured":"Cochat P, Liutkus A, Fargue S, Basmaison O, Ranchin B, Rolland MO (2006) Primary hyperoxaluria type 1: still challenging! Pediatr Nephrol 21:1075\u20131081","journal-title":"Pediatr Nephrol"},{"key":"2329_CR99","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000086356","volume":"25","author":"MB Coulter-Mackie","year":"2005","unstructured":"Coulter-Mackie MB (2005) Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype. Am J Nephrol 25:264\u2013268","journal-title":"Am J Nephrol"},{"key":"2329_CR100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000086362","volume":"25","author":"CJ Danpure","year":"2005","unstructured":"Danpure CJ (2005) Molecular etiology of primary hyperoxaluria type 1: new directions for treatment. Am J Nephrol 25:303\u2013310","journal-title":"Am J Nephrol"},{"key":"2329_CR101","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000085407","volume":"25","author":"DS Milliner","year":"2005","unstructured":"Milliner DS (2005) The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol 25:154\u2013160","journal-title":"Am J Nephrol"},{"key":"2329_CR102","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajhg.2010.07.023","volume":"87","author":"R Belostotsky","year":"2010","unstructured":"Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C, Monico CG, Feinstein S, Ben-Shalom E, Magen D, Weissman I, Charon C, Frishberg Y (2010) Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet 87:392\u2013399","journal-title":"Am J Hum Genet"},{"key":"2329_CR103","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2215\/CJN.02760311","volume":"6","author":"CG Monico","year":"2011","unstructured":"Monico CG, Rossetti S, Belostotsky R, Cogal AG, Herges RM, Seide BM, Olson JB, Bergstrahl EJ, Williams HJ, Haley WE, Frishberg Y, Milliner DS (2011) Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol 6:2289\u20132295","journal-title":"Clin J Am Soc Nephrol"},{"key":"2329_CR104","doi-asserted-by":"crossref","first-page":"e26021","DOI":"10.1371\/journal.pone.0026021","volume":"6","author":"TJ Riedel","year":"2011","unstructured":"Riedel TJ, Johnson LC, Knight J, Hantgan RR, Holmes RP, Lowther WT (2011) Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria. PLoS One 6:e26021","journal-title":"PLoS One"},{"key":"2329_CR105","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1523-1755.2005.00267.x","volume":"67","author":"CG Monico","year":"2005","unstructured":"Monico CG, Rossetti S, Olson JB, Milliner DS (2005) Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 67:1704\u20131709","journal-title":"Kidney Int"},{"key":"2329_CR106","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1681\/ASN.2006111230","volume":"18","author":"CG Monico","year":"2007","unstructured":"Monico CG, Rossetti S, Schwanz HA, Olson JB, Lundquist PA, Dawson DB, Harris PC, Milliner DS (2007) Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J Amer Soc Nephrol 18:1905\u20131914","journal-title":"J Amer Soc Nephrol"},{"key":"2329_CR107","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000086360","volume":"25","author":"JC Lieske","year":"2005","unstructured":"Lieske JC, Monico CG, Holmes WS, Bergstralh EJ, Slezak JM, Rohlinger AL, Olson JB, Milliner DS (2005) International registry for primary hyperoxaluria. Am J Nephrol 25:290\u2013296","journal-title":"Am J Nephrol"},{"key":"2329_CR108","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ki.2009.435","volume":"77","author":"J Harambat","year":"2010","unstructured":"Harambat J, Fargue S, Acquaviva C, Gagnadoux MF, Janssen F, Liutkus A, Mourani C, Macher MA, Abramowicz D, Legendre C, Durrbach A, Tsimaratos M, Nivet H, Girardin E, Schott AM, Rolland MO, Cochat P (2010) Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 77:443\u2013449","journal-title":"Kidney Int"},{"key":"2329_CR109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000086357","volume":"25","author":"Y Frishberg","year":"2005","unstructured":"Frishberg Y, Rinat C, Shalata A, Khatib I, Feinstein S, Becker-Cohen R, Weismann I, Wanders RJ, Rumsby G, Roels F, Mandel H (2005) Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel. Am J Nephrol 25:269\u2013275","journal-title":"Am J Nephrol"},{"key":"2329_CR110","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00467-003-1234-x","volume":"18","author":"B Hoppe","year":"2003","unstructured":"Hoppe B, Langman CB (2003) A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 18:986\u2013991","journal-title":"Pediatr Nephrol"},{"key":"2329_CR111","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.ki.5001821","volume":"70","author":"D Milliner","year":"2006","unstructured":"Milliner D (2006) Treatment of the primary hyperoxalurias: a new chapter. Kidney Int 70:1198\u20131200","journal-title":"Kidney Int"},{"key":"2329_CR112","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00864405","volume":"7","author":"E Leumann","year":"1993","unstructured":"Leumann E, Hoppe B, Neuhaus T (1993) Management of primary hyperoxaluria: efficacy of oral citrate administration. Pediatr Nephrol 7:207\u2013211","journal-title":"Pediatr Nephrol"},{"key":"2329_CR113","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1093\/ndt\/gfr107","volume":"26","author":"B Hoppe","year":"2011","unstructured":"Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschenes G, Unwin R, Milliner D (2011) Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant 26:3609\u20133615","journal-title":"Nephrol Dial Transplant"},{"key":"2329_CR114","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000085411","volume":"25","author":"CG Monico","year":"2005","unstructured":"Monico CG, Olson JB, Milliner DS (2005) Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria. Am J Nephrol 25:183\u2013188","journal-title":"Am J Nephrol"},{"key":"2329_CR115","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/sj.ki.5001806","volume":"70","author":"F Illies","year":"2006","unstructured":"Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF (2006) Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int 70:1642\u20131648","journal-title":"Kidney Int"},{"key":"2329_CR116","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/j.1600-6143.2010.03271.x","volume":"10","author":"EJ Bergstralh","year":"2010","unstructured":"Bergstralh EJ, Monico CG, Lieske JC, Herges RM, Langman CB, Hoppe B, Milliner DS (2010) Transplantation outcomes in primary hyperoxaluria. Am J Transplant 10:2493\u20132501","journal-title":"Am J Transplant"},{"key":"2329_CR117","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/01.TP.0000084203.76110.AC","volume":"76","author":"MT Millan","year":"2003","unstructured":"Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL, Filler G, Salvatierra O Jr, Esquivel CO (2003) One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation 76:1458\u20131463","journal-title":"Transplantation"},{"key":"2329_CR118","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1021\/bi0360758","volume":"43","author":"M Silva","year":"2004","unstructured":"Silva M, Silva CH, Iulek J, Thiemann OH (2004) Three-dimensional structure of human adenine phosphoribosyltransferase and its relation to DHA-urolithiasis. Biochemistry 43:7663\u20137671","journal-title":"Biochemistry"},{"key":"2329_CR119","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3476(97)70162-8","volume":"131","author":"V Matos","year":"1997","unstructured":"Matos V, van Melle G, Boulat O, Markert M, Bachmann C, Guignard JP (1997) Urinary phosphate\/creatinine, calcium\/creatinine, and magnesium\/creatinine ratios in a healthy pediatric population. J Pediatr 131:252\u2013257","journal-title":"J Pediatr"},{"key":"2329_CR120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00467-008-1073-x","volume":"25","author":"B Hoppe","year":"2010","unstructured":"Hoppe B, Kemper MJ (2010) Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol 25:403\u2013413","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 1","key":"2329_CR121","first-page":"13","volume":"11","author":"G Rumsby","year":"1998","unstructured":"Rumsby G (1998) Experience in prenatal diagnosis of primary hyperoxaluria type 1. J Nephrol 11(Suppl 1):13\u201314","journal-title":"J Nephrol"},{"key":"2329_CR122","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/adc.66.4.501","volume":"66","author":"TM Barratt","year":"1991","unstructured":"Barratt TM, Kasidas GP, Murdoch I, Rose GA (1991) Urinary oxalate and glycolate excretion and plasma oxalate concentration. Arch Dis Child 66:501\u2013503","journal-title":"Arch Dis Child"},{"key":"2329_CR123","first-page":"27","volume":"32","author":"C Schnakenburg von","year":"1994","unstructured":"von Schnakenburg C, Byrd DJ, Latta K, Reusz GS, Graf D, Brodehl J (1994) Determination of oxalate excretion in spot urines of healthy children by ion chromatography. Eur J Clin Chem Clin Biochem 32:27\u201329","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"2329_CR124","first-page":"901","volume":"73","author":"DA Gibbs","year":"1969","unstructured":"Gibbs DA, Watts RW (1969) The variation of urinary oxalate excretion with age. J Lab Clin Med 73:901\u2013908","journal-title":"J Lab Clin Med"},{"key":"2329_CR125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0022-3476(05)81696-8","volume":"123","author":"BZ Morgenstern","year":"1993","unstructured":"Morgenstern BZ, Milliner DS, Murphy ME, Simmons PS, Moyer TP, Wilson DM, Smith LH (1993) Urinary oxalate and glycolate excretion patterns in the first year of life: a longitudinal study. J Pediatr 123:248\u2013251","journal-title":"J Pediatr"},{"key":"2329_CR126","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1542\/peds.84.5.860","volume":"84","author":"T Campfield","year":"1989","unstructured":"Campfield T, Braden G (1989) Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition. Pediatrics 84:860\u2013863","journal-title":"Pediatrics"},{"key":"2329_CR127","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199412083312304","volume":"331","author":"DS Milliner","year":"1994","unstructured":"Milliner DS, Eickholt JT, Bergstralh EJ, Wilson DM, Smith LH (1994) Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 331:1553\u20131558","journal-title":"N Engl J Med"},{"key":"2329_CR128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000184364","volume":"46","author":"SH Morgan","year":"1987","unstructured":"Morgan SH, Purkiss P, Watts RW, Mansell MA (1987) Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron 46:253\u2013257","journal-title":"Nephron"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2329-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-012-2329-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2329-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T03:32:18Z","timestamp":1644118338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-012-2329-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,20]]},"references-count":128,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2329"],"URL":"https:\/\/doi.org\/10.1007\/s00467-012-2329-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,20]]}}}